PuSH - Publikationsserver des Helmholtz Zentrums München

26 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
Harman, N.L.* et al.: Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes. J. Transl. Med. 18:468 (2020)
Körber, N. ; Behrends, U. ; Protzer, U. & Bauer, T.: Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting. J. Transl. Med. 18:242 (2020)
Bao, X. ; Anastasov, N. ; Wang, Y.* & Rosemann, M.: A novel epigenetic signature for overall survival prediction in patients with breast cancer. J. Transl. Med. 17:380 (2019)
Wen, W.* et al.: Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. J. Transl. Med. 17:186 (2019)
Gary, R.* et al.: Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. J. Transl. Med. 16:124 (2018)
Slotta-Huspenina, J.* et al.: Correction: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus [J Transl Med., 16, (2018) (109)] DOI: 10.1186/s12967-018-1492-9. J. Transl. Med. 16:128 (2018)
Slotta-Huspenina, J.* et al.: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus. J. Transl. Med. 16:109 (2018)
Halama, A.* et al.: Measurement of 1,5-anhydroglucitol in blood and saliva: From non-targeted metabolomics to biochemical assay. J. Transl. Med. 14:140 (2016)
Körber, N. ; Behrends, U. ; Hapfelmeier, A.* ; Protzer, U. & Bauer, T.: Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring. J. Transl. Med. 14:175 (2016)
Halama, A.* et al.: Metabolic signatures differentiate ovarian from colon cancer cell lines. J. Transl. Med. 13:223 (2015)
Grabe, H.J.* et al.: Cohort profile: Greifswald approach to individualized medicine (GANI_MED). J. Transl. Med. 12:144 (2014)
Mathew, S.* et al.: Metabolomics of Ramadan fasting: An opportunity for the controlled study of physiological responses to food intake. J. Transl. Med. 12:161 (2014)
Roehnisch, T.* et al.: Phage idiotype vaccination: First phase I/II clinical trial in patients with multiple myeloma. J. Transl. Med. 12:119 (2014)
Roehnisch, T.* et al.: Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model. J. Transl. Med. 11:267 (2013)
Ruf, P.* et al.: Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model. J. Transl. Med. 10:219 (2012)
Spranger, S. ; Frankenberger, B. & Schendel, D.J.: NOD/scid IL-2Rgnull mice: A preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo. J. Transl. Med. 10:30 (2012)
Beck, B.* et al.: Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission. J. Transl. Med. 9:151 (2011)
Fox, B.A.* et al.: Defining the critical hurdles in cancer immunotherapy. J. Transl. Med. 9:214 (2011)
Bürdek, M. et al.: Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation. J. Transl. Med. 8:90 (2010)